Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer.
Overman MJ, Adam L, Raghav K, Wang J, Kee B, Fogelman D, Eng C, Vilar E, Shroff R, Dasari A, Wolff R, Morris J, Karunasena E, Pisanic TR 2nd, Azad N, Kopetz S.
Overman MJ, et al. Among authors: kopetz s.
Ann Oncol. 2018 Jan 1;29(1):139-144. doi: 10.1093/annonc/mdx688.
Ann Oncol. 2018.
PMID: 29069279
Free PMC article.
Clinical Trial.